Neuraxpharm Vows Swift Appeal Over Pulled EU Tecfidera Generics

CNS Specialist Says Decision Was ‘Rooted In A Highly Disputed Legal Interpretation’

 
• By Dave Wallace
  
EU court of justice - Luxenbourg
Neuraxpharm says it will ‘swiftly contest’ the decision to pull generics from the market

More from Legal & IP

More from Generics Bulletin